Post-transplantation HTLV-1 myelopathy in three recipients from a single donor

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 8, 2003, Pages 1080-1084

  Zarranz Imirizaldu, J J ^a   Gomez Esteban, J C ^a   Rouco Axpe, I ^a   Perez Concha, T ^a   Velasco Juanes, F ^a   Allue Susaeta, I ^a   Corral Carranceja, J M ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; CYCLOSPORIN; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; METHYLPREDNISOLONE; PREDNISONE;

AMINO ACID SEQUENCE; ANTIBODY SCREENING; ARTICLE; BLOOD BANK; CEREBROSPINAL FLUID; DNA DETERMINATION; ENZYME IMMUNOASSAY; EVOKED SOMATOSENSORY RESPONSE; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROPREVALENCE; SPINAL CORD DISEASE; TREATMENT FAILURE; VIRUS LOAD; WESTERN BLOTTING;

EID: 0042205103     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.8.1080     Document Type: Article

References (46)

1. Gessain A, Vernant JC, Maurs L, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;ii:407-10.
2. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986;ii:1031-2.
3. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999;353:1951-8.
4. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-19.
5. Cann AJ, Chen ISY. Human T-cell leukemia virus types I and II. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields virology Vol 59. Philadelphia: Raven, 1996:1849-80.
6. Hernandez Ramirez P, Rivero Jimenez R, et al. Very low seroprevalence of HTLV-I/II in Cuba: antibodies in blood donors and in haematological and nonhaematological patients. Vox Sang 1991;61:277-8.
7. Reeves WC, Levine PH, Cuevas M, et al. Seroepidemiology of human T cell lymphotropic virus in the Republic of Panama. Am J Trop Med Hyg 1990;42:374-9.
8. Murphy EL, Figueroa JP, Gibbs WN, et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 1991;133:1114-24.
9. Morofuji-Hirata M, Kajiyama W, Nakashima K, et al. Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years. Am J Epidemiol 1993;137:43-8.
10. Lillo F, Varnier OE, Sabbatani S, et al. Detection of HTLV-I and not HTLV-II infection in Guinea Bissau (west Africa). J Acquir Immune Defic Syndr 1991;4:541-2.
11. Dumas M, Houinato D, Verdier M, et al. Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa). AIDS Res Hum Retroviruses 1991;7:447-51.
12. Delaporte E, Monplaisir N, Louwagie J, et al. Prevalence of HTLV-I and HTLV-II infection in Gabon, Africa: comparison of the serological and PCR results. Int J Cancer 1991;49:373-6.
13. Wiktor SZ, Piot P, Mann JM, et al. Human T cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire. J Infect Dis 1990;161:1073-7.
14. Mueller N, Okayama A, Stuver S, et al. Findings from the Miyazaki Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13 (suppl 1):S2-7.
15. Soriano V, Gutiérrez M, Vallejo A, et al. Infección por HTLV-1 en España. Análisis de 24 casos identificados hasta noviembre de 1994. Med Clin 1995;105:246-50.
16. Toro C, Rodes B, Aguilera A, et al. Clinical impact of HTLV-1 infection in Spain: implications for public health and mandatory screening. J Acquir Immune Defic Syndr 2002;30:366-8.
17. Manns A, Wilks RJ, Murphy EL, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992;51:886-91.
18. Hino S, Yamaguchi K, Katamine S, et al. Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res 1985;76:474-80.
19. Wiktor SZ, Pate EJ, Rosenberg PS, et al. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol 1997;1:37-44.
20. Stuver SO, Tachibana N, Okayama A, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis 1993;167:57-65.
21. Kamihira S, Nakasima S, Oyakawa Y, et al. Transmission of human T cell lymphotropic virus type I by blood transfusion before and after mass screening of sera from seropositive donors. Vox Sang 1987;52:43-44.
22. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984;46:245-53.
23. Kaplan JE, Osame M, Kubota H, et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990;3:1096-01.
24. Osome M, Izumo S, Igata A, et al. Blood transfusion and HTLV-I associated myelopathy. Lancet 1986;ii:104-5.
25. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990;322:383-8.
26. Rosenblum MK, Brew BJ, Hahn B, et al. Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome. Hum Pathol 1992;23:513-19.
27. Lleó A, Planella M, Domingo P. Mielopatía e infección por el virus de la inmunodeficiencia humana. Med Clin 1999;112:423-7.
28. Usuku K, Nishizawa M, Matsuki K, et al. Association of a particular amino acid sequence of the HLA-DR beta 1 chain with HTLV-I-associated myelopathy. Eur J Immunol 1990;20:1603-6.
29. Jeffery KJ, Siddiqui AA, Bunce M, et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000;165:7278-84.
30. Jeffery KJM, Usuku K, Matsumoto W, et al. HLA allels determine human T lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I associated myelopathy. Proc Natl Acad Sci USA 1999;96:3848-53.
31. Zarranz JJ, Rouco I, Gomez-Esteban JC, et al. Human T lymphotropic virus type I (HTLV-1) associated myelopathy acquired through a liver transplant. J Neurol Neurosurg Psychiatry 2001;71:818.
32. Bangham CRM. HTLV-1 infections. J Clin Pathol 2000;53:581-6.
33. Izumo S, Goto I, Itoyama Y, et al. Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 1996;46:1016-21.
34. Taylor GP. Pathogenesis and treatment of HTLV-1 associated myelopathy. Sex Transm Inf 1998;74:316-22.
35. Toro C, Rhodes B, Poveda E, et al. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation 2003;75:102-4.
36. Jeffery KJM, Usuku K, Matsumoto W, et al. HLA alleles determine human T lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I associated myelopathy. Proc Natl Acad Sci USA 1999;96:3848-53.
37. Aye MM, Matsuoka E, Moritoyo T, et al. Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol (Berl) 2000;100:245-52.
38. Kira J, Fujihara K, Itoyama Y, et al. Leukoencephalopathy in HTLV-I associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neurol Sci 1991;106:41-9.
39. Courouce AM, Pillonel J, Lemaire JM, et al. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. AIDS 1993;7:841-7.
40. Soriano V, Mas A, Riesgo actual de transmisión de retrovirus por transfusiones. Sangre 1995;5:407-16.
41. Nakamura N, Arakaki Y, Sunagawa H, et al. Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplant Proc 1998;30:1324-6.
42. Niewiesk S, Daenke S, Parker CE, et al. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol 1995;69:2649-53.
43. Nakane S, Shirabe S, Moriuchi R, et al. Comparative molecular analysis of HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant HTLV-I-associated myelopathy in monozygotic twins. J Neurovirol 2000;6:275-83.
44. Furukawa Y, Yamashita M, Usuku K, et al. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2000;182:1343-9.
45. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998;4:586-93.
46. Manns A, Miley WJ, Wilks RJ, et al. Quantitative proviral DNA and antibody levels in the natural history of HTLV-Infection. J Infect Dis 1999;180:1487-93.